ExLibris header image
SFX Logo
Title: A Phase I Study of PD 0332991: Complete CDK4/6 Inhibition and Tumor Response In Sequential Combination with Bortezomib and Dexamethasone for Relapsed and Refractory Multiple Myeloma
Source:

Blood [0006-4971] Niesvizky, Ruben yr:2010


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. "Lenalidomide Shuts Down the Translational Machinery in Multiple Myeloma Cells Resulting in Down-Regulation of Critical Transcription Factors Such as C/EBPβ and IRF4." Blood. 114.22: 1844-1844. Link to SFX for this item
2. "Targeting CDK4/CDK6 Impairs Osteoclast Progenitor Pool Expansion and Blocks Osteolytic Lesion Development in Multiple Myeloma." Blood : journal of the American Society of Hematology. 114.22: 298-298. Link to SFX for this item
Select All Clear All

Expand list of advanced services Advanced